Canada’s main stock index continued its downward trend on Thursday after recent success from a few days ago. The materials sector weighed on the TSX as copper prices fell, adding to declines sustained in an otherwise broad-based drop where only the telecom market saw any growth.

The tech-heavy Nasdaq followed up its worst performance since 2022 in the previous session with another dive into the red along with the other two main indices.

TSX22,726.76-124.41TSX
TSXV578.85-9.32TSXV
CSE170.92-0.74CSE
DJIA40,665.02-533.06DJIA
NASDAQ17,871.22-125.70NASDAQ
S&P 5005,545.82-42.45S&P 500

The Canadian dollar traded for 72.91 cents U.S. compared with 73.05 cents U.S. on Wednesday.

U.S. crude futures traded $0.52 lower at $82.33 a barrel, and the Brent contract lost $0.37 to $84.71 a barrel.

The price of gold was down US$17.68 to US$2,443.70.

In world markets, the Nikkei was down 971.34 points to 40,126.35, the Hang Seng was up 39.00 points to 17,778.41, the FTSE was up 17.43 points to 8,204.89, and the DAX was down 82.54 points to 18,354.76.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

(Top image: File)


More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.